Prismic Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing novel prescription medical foods for the clinical dietary management of the metabolic processes associated with disorders commonly seen in the aging “baby boomer” population. These include disorders of the central nervous system (CNS), as well as conditions where inflammation is an underlying or significant cause of the disorder.

The company's initial product candidates are focused on the use of a highly purified form of Omega-3 fatty acids in combination with other molecules for the treatment of CNS disorders, and are protected by a series of issued U.S. and foreign composition and use patents. 

Prismic plans to develop novel medical food products internally and partner with pharmaceutical companies to develop and commercialize prescription products in the CNS area that utilize Prismic’s broad patent portfolio.

There is a considerable and growing body of data, including Phase 3 clinical studies, demonstrating the efficacy of highly purified Omega-3 fatty acids in a number of CNS disorders.  The company, therefore, believes that there is a tremendous opportunity for Prismic and its partners to, relatively expeditiously, bring patent-protected formulations to market in significant therapeutic treatment areas where there is a clear need for safer and highly efficacious products.

The company is also in the process of concluding licensing agreements to secure the U.S. rights for additional products that address the needs of patients where inflammation is the underlying or a significant cause of the disorder.

Prismic Pharmaceuticals is unique in that it is committed to minimizing the number of direct employees, and maximizing the use of technology in order to achieve exceptional levels of productivity and profitability.   To this end, the company has established partnerships with technology companies to provide highly customized applications, including live video meetings, that will allow Prismic to, cost-effectively, conduct a large percentage of its interactions with targeted physicians remotely and at the convenience of the physicians.  These interactions will include key opinion leader meetings, speaker programs, medical science liaison support, and face-to-face, onscreen educational and sales/detailing sessions.

Prismic is headquartered in Scottsdale, Arizona, USA.